NCT06852222 · Interventional trial
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Overall registry status Recruiting
Phase 3
Conditions Leukemia, Myeloid, Acute
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory